HEALTH● LOW1h ago · Sep 8, 2026, 5:00 AM
Cholesterol drug setback casts doubt over multibillion-dollar race
CNBC · global
Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH55m agoPolice investigation into endometriosis surgeon droppedgleninnesexaminer.com.au · AustraliaHEALTH1h agoSecond-hand smoke: 2.7 billion exposed, 767 million of them children, study findsEuroNews [en]HEALTH1h agoFirst - Of - Its - Kind Wellbeing Pod Opens At Christchurch Schoolscoop.co.nz · New ZealandHEALTH2h agoISpecimen In Focus , Genelux Nears Phase 3 Ovarian Cancer Data , Biofrontera Awaits FDA Decisionrttnews.com · United States